Serial Number 97648644
688

Registration Progress

Application Filed
Oct 26, 2022
Under Examination
Apr 22, 2025
Approved for Publication
Feb 25, 2025
Published for Opposition
Feb 25, 2025
Registered

Trademark Image

Basic Information

Serial Number
97648644
Deadline
October 22, 2025
Description
Statement of Use or 1st Extension Due
Filing Date
October 26, 2022
Published for Opposition
February 25, 2025
Drawing Code
2

Status Summary

Current Status
Active
Status Code
688
Status Date
Apr 22, 2025
Application
Pending
Classes
001 005

Rights Holder

Biosynth AG

03
Address
Rietlistrasse 4
Staad 9422
CH

Ownership History

Biosynth AG

Original Applicant
03
Staad CH

Biosynth AG

Owner at Publication
03
Staad CH

Legal Representation

Attorney
Tara Reedy Sliva

Application History

24 events
Date Code Type Description
Apr 22, 2025 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 25, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 25, 2025 PUBO A PUBLISHED FOR OPPOSITION
Feb 19, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 31, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 30, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 30, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 30, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 30, 2024 CNRT R NON-FINAL ACTION WRITTEN
Oct 30, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 30, 2024 GNRT F NON-FINAL ACTION E-MAILED
Oct 22, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 22, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 22, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 22, 2024 CNRT R NON-FINAL ACTION WRITTEN
Jul 22, 2024 CNRT R NON-FINAL ACTION WRITTEN
Jul 22, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 22, 2024 GNRT F NON-FINAL ACTION E-MAILED
Jul 22, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 22, 2024 GNRT F NON-FINAL ACTION E-MAILED
Jul 17, 2024 DOCK D ASSIGNED TO EXAMINER
Nov 10, 2022 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED
Nov 9, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 29, 2022 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 001
Biochemicals and organic chemicals used as enzyme substrates, enzyme inducers, namely, aminoglutethimides, carbamazepines, griseofulvins, and primidones, enzyme inactivators, or cultural medium additives for use in the field of microbiology and molecular biology for scientific purposes; biochemical and organic chemical reagents for clinical diagnostic laboratory use; biochemical and organic chemicals for use in the manufacture of pharmaceuticals and cosmetics; Chemical reagents for medical research use in the field of immunology
Class 005
Medicinal preparations, namely, photosensitizing agents used as a dermatologic drug for the treatment of skin cancer by phototherapy; Chemical reagents for medical or veterinarian use; Chemical reagents for use as culture media for cultures of microorganisms for medical use, namely, for the isolation and identification of the bacteria strain Escherichia coli O157:H7; Chemical preparations for medical purposes, namely, for Cholesterol testing to prevent possible consequences of Hypercholesterolemia such as atherosclerosis, coronary heart disease and other forms of cardiovascular diseases; Chemical preparations for medical purposes, namely, for novel enzyme responsive inhibitors that allow for modifications of the composition of microbial communities; Organic chemical preparations for medical purposes, namely, immunomodulators with anti-inflammatory properties; Organic chemical preparations and enzymes for medical laboratory analysis purposes, namely, for medical detection, identification and quantification of strains of pathogenic bacteria; Chemical preparations for medical laboratory analysis purposes, namely, for medical immunological and microbiological blood testing; Chemical preparations for medical laboratory analysis purposes, namely, for medical detection of pathogenic bacteria, namely, various strains of Listeria, Clostridium, Bacillus and Staphylococcus; Chemical preparations for medical laboratory analysis purposes, namely, for the medical detection and quantification of bacteria strains of Escherichia coli; Medical preparations for the diagnosis of Staphylococus aureus, in particular for Methicillin-resistant Staphylococcus aureus (MRSA); Chemical reagents for medical laboratory analysis purposes, namely, for use as a routine medical supplement to blood culture media in vitro to inhibit blood coagulation and to improve the detection limits for individual microorganisms

Additional Information

Design Mark
The mark consists of four stacked wavy lines in the colors of navy, orange, teal and blue. The wavy lines are intersected with lines forming four overlapping diamonds that are comprised of four smaller diamonds. The top quadrant of the diamonds is in navy for the top half and orange for the bottom half. The left and right quadrants of the diamonds are in orange for the top half and teal for the bottom half. The bottom quadrant of the diamonds is in teal for the top half and blue for the bottom half. The color white represents background and/or transparent areas and is not a feature of the mark.
Color Claim
The color(s) navy, orange, teal and blue is/are claimed as a feature of the mark.

Classification

International Classes
001 005